Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, 2022, to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion … [Read more…]

HCA Healthcare Veteran Executive Bruce Moore to Retire After 40-Year Career With the Company

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA) today announced that longtime executive Bruce Moore, president – service line and operations integration, will retire at the end of the year after a 40-year career with the company. Under Moore’s leadership HCA Healthcare’s network of care capabilities have grown considerably. This includes a behavioral health services platform … [Read more…]

Aditxt, Inc. (Nasdaq: ADTX) Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening on September 14, 2022

RICHMOND, Va.–(BUSINESS WIRE)–Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, announced today that it will effect a 1-for-50 reverse split of its common stock effective as of 4:01 p.m. Eastern Time on September 13, 2022. Commencing with the opening of trading on The … [Read more…]

McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer

Tracy L. Faber to Retire After More Than a Decade at the Company IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE:MCK) today announced that LeAnn B. Smith has been selected to become executive vice president and chief human resources officer (CHRO). Ms. Smith will succeed Tracy L. Faber, McKesson’s current CHRO, who will be retiring after an accomplished … [Read more…]

Syros Receives FDA Orphan Drug Designation for SY-5609 for the Treatment of Pancreatic Cancer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to SY-5609 for the treatment of pancreatic cancer. SY-5609, a highly selective and potent oral cyclin-dependent kinase 7 (CDK7) inhibitor, … [Read more…]

AdvoCare® Hosts “You’ve Got This” Virtual Event on September 13 – to Motivate and Spread Positivity in the Busy Fall and Holiday Seasons

Featured Speakers and Health Professionals Presenting Tips on How to Stay Healthy and Balanced – With AdvoCare Offering Attendees a Chance to Win $10,000 for Guessing the Spark® Mystery Flavor RICHARDSON, Texas–(BUSINESS WIRE)–#AdvoCareSpark—AdvoCare International, LLC, a health and wellness company, hosts “You’ve Got This” virtual event to motivate and to help everyone make the most … [Read more…]

Kyruus Announces Acquisition of Leading Digital Patient Engagement Company, Epion Health

Combined company will offer the most comprehensive patient access and engagement solutions in the market BOSTON & HOBOKEN, N.J.–(BUSINESS WIRE)–Kyruus, the leader in provider search and scheduling solutions for healthcare organizations, today announced it will acquire Epion Health, a leader in digital patient engagement solutions. The two companies will join forces to offer healthcare organizations … [Read more…]

Compass Group Announces Launch of Interventional Pain Management Platform with Anchor Investment in Leading Memphis Practice

ST. LOUIS–(BUSINESS WIRE)–Compass Group Equity Partners, a St. Louis-based private equity firm, today announced a strategic partnership with Mays & Schnapp Neurospine and Pain (“Mays & Schnapp”), a Memphis-based interventional pain management practice serving patients in Tennessee and Mississippi. “We chose to partner with the Compass team because we share a mutual vision in building … [Read more…]

Global Liquid Biopsy Market Analysis Report 2022: A $10.4 Billion Market by 2027 – Opportunities in Reference Laboratories, Hospitals and Physician Laboratories, and Academic and Research Centers – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Liquid Biopsy Market to 2027: Market Size, Trends and Growth Analysis” report has been added to ResearchAndMarkets.com’s offering. The global liquid biopsy market is expected to reach an estimated $10.4 billion by 2027 with a CAGR of 17.9% from 2022 to 2027. The future of the global liquid biopsy market looks promising with … [Read more…]

Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Bipolar Disorder Therapeutics Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global bipolar disorder therapeutics market is expected to grow from $6.00 billion in 2021 to $6.47 billion in 2022 at a compound annual growth rate (CAGR) of 7.8%. The bipolar disorder therapeutics market is expected to grow to … [Read more…]